All In Biotech

Drug Trial Radar · NCT06345339

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 2,701 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

2,701

Actual

Start

Apr 26, 2024

Primary completion

Sep 2027

Study completion Jun 2028

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Apr 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone \[TSH\]) on synthetic T4 treatment. This study will also therefore evaluate the efficacy and safety of dose conversion from synthetic T4 therapy to Armour Thyroid therapy.

Conditions

  • Hypothyroidism

Interventions

  • Armour ThyroidDrug

    Oral Capsule or Tablet

  • LevothyroxineDrug

    Oral Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants who Achieve Thyroid-Stimulating Hormone (TSH) ResponseTime frame: Week 55
  2. Number of Participants with Adverse Events (AEs)Time frame: Up to approximately 90 weeks

Locations

139 sites in 2 countries. Site status is shown where the registry gives one.

  • Central Research Associates /ID# 255719

    Birmingham, Alabama

  • UAB Hospital /ID# 262565

    Birmingham, Alabama

  • Kaiser San Diego Dept Endocrinology, SCPMG /ID# 262552

    Bonita, California

  • Facey Medical Foundation - Burbank /ID# 262104

    Burbank, California

  • John Muir Medical Center /ID# 257103

    Concord, California

  • Diagnamics Inc. /ID# 262680

    Encinitas, California

  • Providence - St. Jude Medical Center /ID# 256520

    Fullerton, California

  • NorCal Medical Research /ID# 256512

    Greenbrae, California

  • Velocity Clinical Research - Huntington Park /ID# 259044

    Huntington Park, California

  • Scripps Whittier Diabetes Institute /ID# 259215

    La Jolla, California

  • Facey Medical Foundation /ID# 260863

    Mission Hills, California

  • Hoag Memorial Hospital Presbyterian /ID# 260990

    Newport Beach, California

  • Diabetes Associates Medical Group /ID# 256949

    Orange, California

  • Western University of Health Sciences /ID# 262183

    Pomona, California

  • Research at Mills-Peninsula Medical Center - Sutter Health /ID# 258825

    San Mateo, California

  • Care Access - Santa Clarita /ID# 262573

    Santa Clarita, California

  • Facey Medical Foundation - Valencia /ID# 262102

    Santa Clarita, California

  • Olive View UCLA Medical Center /ID# 259092

    Sylmar, California

  • The Lundquist Institute at Harbor-UCLA Medical Center /ID# 262572

    Torrance, California

  • Diablo Clinical Research /ID# 261329

    Walnut Creek, California

  • San Fernando Valley Health Institute - West Hills /ID# 257363

    West Hills, California

  • New England Research Associates - Bridgeport /ID# 262184

    Bridgeport, Connecticut

  • Innovative Research of West Florida /ID# 257356

    Clearwater, Florida

  • ALL Medical Research /ID# 256748

    Cooper City, Florida

  • Northeast Research Institute (NERI) /ID# 261841

    Fleming Island, Florida

  • Northeast Research Institute (NERI) /ID# 261846

    Fleming Island, Florida

  • The Center for Diabetes and Endocrine Care /ID# 255721

    Fort Lauderdale, Florida

  • Encore Medical Research /ID# 256758

    Hollywood, Florida

  • East Coast Institute For Research - LaVilla - West Monroe Street /ID# 256972

    Jacksonville, Florida

  • The University of Florida Heal /ID# 257361

    Jacksonville, Florida

  • East Coast Research - Jacksonville /ID# 256971

    Jacksonville, Florida

  • Encore Research Group-Jacksonville Center for Clinical Research /ID# 256147

    Jacksonville, Florida

  • Baptist Health Research Institute /ID# 260989

    Jacksonville, Florida

  • South Florida Wellness & Clinic /ID# 256513

    Margate, Florida

  • Med Research of Florida /ID# 257837

    Miami, Florida

  • Ocean Blue Medical Research Center, Inc /ID# 260438

    Miami Springs, Florida

  • Adult Medicine of Lake County - Mount Dora /ID# 257371

    Mt. Dora, Florida

  • Suncoast Clinical Research Pasco County /ID# 257018

    New Port Richey, Florida

  • West Orange Endocrinology /ID# 256139

    Ocoee, Florida

  • Suncoast Clinical Research - Palm Harbor /ID# 256741

    Palm Harbor, Florida

Showing 40 of 139 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.